For a comprehensive list of vaccines, refer to the Centers for Disease Control and Prevention web site at cdc.gov/vaccines/
Dosing is individualized based on baseline labs, age, body composition, and response
Emerging research on melanocortin-4 receptor (MC4R) agonists combined with GLP-1/GIP agonists has shown promise for enhanced weight loss and prevention of weight regain, potentially addressing the needs of patients who plateau on current monotherapy [53]
By working closely with healthcare providers and exploring effective treatment options, women can embrace menopause with confidence and vitality, knowing that they have the tools and support they need to thrive
Network meta-analyses were also eligible if they provided direct pairwise comparisons between GLP-1 RAs and relevant control groups
Manufactured by Novo Nordisk at a list price approaching $1,000 per month, Wegovy was also the drug that most patients associated with the GLP-1 weight loss revolution